Splenic Marginal Zone Lymphoma — Trials

Splenic Marginal Zone Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

135 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 9%
Top sponsor: City of Hope Medical Center
Termination share: 38.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06859008	Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma	recruiting	Phase 1	37	City of Hope Medical CenterOTHER	1	Apr 20, 2026	clinicaltrials
NCT05544019	Study of SGR-1505 in Mature B-Cell Neoplasms	recruiting	Phase 1	98	Schrödinger, Inc.INDUSTRY	8	Feb 13, 2026	clinicaltrials